IL-6 is not essential for exercise-induced increases in glucose uptake.

Interleukin-6 (IL-6) increases glucose uptake in resting skeletal muscle. IL-6 is released from skeletal muscle during exercise; however; it is not known whether this IL-6 response is important for exercise-induced increases in skeletal muscle glucose uptake. We report that IL-6 knockout (KO) mice, 4 mo of age, have similar body weight to wild-type (WT), and, under resting conditions, oxygen consumption, food intake, substrate utilization, glucose tolerance, and insulin sensitivity are not different. Maximal exercise capacity is also similar to WT. We investigated substrate utilization and glucose clearance in vivo during steady-state treadmill running at 70% of maximal running speed and found that WT and IL-6 KO mice had similar rates of substrate utilization, muscle glucose clearance, and phosphorylation of AMP-activated protein kinase T172. These data provide evidence that IL-6 does not play a major role in regulating substrate utilization or skeletal muscle glucose uptake during steady-state endurance exercise.

[1]  V. Wallenius,et al.  Interleukin‐6 mediates exercise‐induced increase in insulin sensitivity in mice , 2012, Experimental physiology.

[2]  M. Tarnopolsky,et al.  AMP-activated protein kinase (AMPK) β1β2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise , 2011, Proceedings of the National Academy of Sciences.

[3]  H. Pilegaard,et al.  Interleukin‐6 modifies mRNA expression in mouse skeletal muscle , 2011, Acta physiologica.

[4]  B. Kemp,et al.  Whole Body Deletion of AMP-activated Protein Kinase β2 Reduces Muscle AMPK Activity and Exercise Capacity* , 2010, The Journal of Biological Chemistry.

[5]  P. Meikle,et al.  Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance , 2010, Diabetologia.

[6]  J. Treebak,et al.  Genetic impairment of AMPKalpha2 signaling does not reduce muscle glucose uptake during treadmill exercise in mice. , 2009, American journal of physiology. Endocrinology and metabolism.

[7]  B. Kemp,et al.  Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity , 2009, Diabetologia.

[8]  N. Ruderman,et al.  Activation of AMP-Activated Protein Kinase by Interleukin-6 in Rat Skeletal Muscle , 2009, Diabetes.

[9]  N. Ruderman,et al.  AMPK and the biochemistry of exercise: implications for human health and disease. , 2009, The Biochemical journal.

[10]  B. Viollet,et al.  Role of adenosine 5'-monophosphate-activated protein kinase in interleukin-6 release from isolated mouse skeletal muscle. , 2009, Endocrinology.

[11]  M. Lorenzo,et al.  Dual Role of Interleukin-6 in Regulating Insulin Sensitivity in Murine Skeletal Muscle , 2008, Diabetes.

[12]  M. Febbraio,et al.  Muscle as an endocrine organ: focus on muscle-derived interleukin-6. , 2008, Physiological reviews.

[13]  P. Geiger,et al.  IL-6 increases muscle insulin sensitivity only at superphysiological levels. , 2007, American journal of physiology. Endocrinology and metabolism.

[14]  F. Lönnqvist,et al.  Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. , 2006, Molecular endocrinology.

[15]  D. James,et al.  Interleukin-6 Increases Insulin-Stimulated Glucose Disposal in Humans and Glucose Uptake and Fatty Acid Oxidation In Vitro via AMP-Activated Protein Kinase , 2006, Diabetes.

[16]  G. Hjälm,et al.  The 5′-AMP-activated Protein Kinase γ3 Isoform Has a Key Role in Carbohydrate and Lipid Metabolism in Glycolytic Skeletal Muscle* , 2004, Journal of Biological Chemistry.

[17]  B. Pedersen,et al.  AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. , 2004, Biochemical and biophysical research communications.

[18]  G. Bergström,et al.  Reduced exercise endurance in interleukin-6-deficient mice. , 2004, Endocrinology.

[19]  Peter Schjerling,et al.  Knockout of the α2 but Not α1 5′-AMP-activated Protein Kinase Isoform Abolishes 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranosidebut Not Contraction-induced Glucose Uptake in Skeletal Muscle* , 2004, Journal of Biological Chemistry.

[20]  B. Pedersen,et al.  Interleukin-6 release from human skeletal muscle during exercise: relation to AMPK activity. , 2003, Journal of applied physiology.

[21]  G. Brooks,et al.  Balance of carbohydrate and lipid utilization during exercise: the "crossover" concept. , 1994, Journal of applied physiology.

[22]  R. Zinkernagel,et al.  Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.

[23]  K. Frayn,et al.  Calculation of substrate oxidation rates in vivo from gaseous exchange. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[24]  O. H. Lowry,et al.  An enzymic method for measurement of glycogen. , 1967, Analytical biochemistry.

[25]  B. Viollet,et al.  Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. , 2004, The Journal of biological chemistry.

[26]  C. Ohlsson,et al.  Interleukin-6-deficient mice develop mature-onset obesity , 2002, Nature Medicine.

[27]  M. Kjaer.  Regulation of hormonal and metabolic responses during exercise in humans. , 1992, Exercise and sport sciences reviews.